NCT07239609 ACT for Individuals With MNCD and Their Care Partners
| NCT ID | NCT07239609 |
| Status | Recruiting |
| Phase | Phase 1 |
| Sponsor | Texas Tech University |
| Condition | Depression in Adults |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2027-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 1 is the earliest stage of human testing — safety and dosage are the primary focus. Visits are frequent and medical supervision is intensive. You will be among the first people to receive this treatment.
This trial targets 100 participants in total. It began in 2026-04-01 with a primary completion date of 2027-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project aims to implement and evaluate a dyadic intervention (i.e., acceptance commitment therapy) for persons with AD/ADRD and their care partners. We hypothesize the intervention will be feasible, acceptable, and show preliminary efficacy of the dyadic interveniotns.
Eligibility Criteria
Inclusion Criteria Inclusion (person with MCI or MNCD): * 18+ * MMSE= 21-27 * Able to communicate in English Inclusion (care partner): * 18+ * Identifies as a care partner of a person with MNCD * Able to communicate in English * MMSE= 28-30 * Is a family member or friend of the person with MNCD Exclusion Criteria Exclusion (person with MCI or MNCD): * Currently in an intervention for reducing anxiety or depression related to their dementia * MMSE= 28+ or less than 21 Exclusion (care partner): * MMSE= \<28 * Is a formal (paid) caregiver
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07239609 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Depression in Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07239609 trial and what does that mean for participants?
Phase 1 trials are the first stage of human testing. The primary goal is to assess safety and determine appropriate dosage levels. Participants are closely monitored. These trials typically involve a small number of volunteers.
Is NCT07239609 currently recruiting?
Yes, NCT07239609 is actively recruiting participants. Contact the research team at jonsinge@ttu.edu for enrollment information.
Where is the NCT07239609 trial being conducted?
This trial is being conducted at Lubbock, United States.
Who is sponsoring the NCT07239609 clinical trial?
NCT07239609 is sponsored by Texas Tech University. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.